Up for Mischief? IL-17/Th17 in the tumour microenvironment.
about
The gastrointestinal tumor microenvironmentTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeIL-17 mediated inflammation promotes tumor growth and progression in the skinCancer immunotherapy: how low-level ionizing radiation can play a key role.SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytesPersonalising pancreas cancer treatment: When tissue is the issue.The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.Distinct eosinophil cytokine expression patterns in skin diseases - the possible existence of functionally different eosinophil subpopulations.Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma.Promotion of lung tumor growth by interleukin-17Plasticity of γδ T Cells: Impact on the Anti-Tumor ResponseIncreased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study.Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.A novel pro-lymphangiogenic function for Th17/IL-17.Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaImmunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance.Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African AmericansType17 T-cells in central nervous system autoimmunity and tumors.Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.NFAT1 supports tumor-induced anergy of CD4(+) T cellsScutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice.Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesAssociation between IL17 polymorphisms and risk of cervical cancer in Chinese womenTumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.Generation and immunologic functions of Th17 cells in malignant gliomas.An essential role for decorin in bladder cancer invasiveness.IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.Role of IL-17 in Glioma ProgressionInterleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients.Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis.Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.
P2860
Q26827391-51335652-06C5-4C89-86E4-D5D4F004DE8EQ28066522-F09F050C-D188-4071-B68C-52BB2B0FA7D9Q28480915-BB906A57-30DB-4CA1-8138-D347C6CDB98DQ30235014-7691AC0D-CCA2-4AA9-A0CF-0AFB23BCA386Q33648604-D7879E89-38B7-4D28-9E23-C8E577FC3165Q33801384-5C6B1DFE-7650-4669-87DE-4C56561CF4D4Q33954291-209EF67C-F04E-4466-8862-3C021FE5DA9DQ34007831-09BCCFA2-E7EB-4F88-B701-0BEA0FDA4188Q34031403-CB50E0B3-F87B-4F2E-B27A-F237A0B66F94Q34201267-111491BE-E0AB-432F-BFE4-7E9BCC4123FAQ34652408-4AC9CBDE-99CF-4C7F-9FAE-92B51EABD714Q34658445-EDC80E8D-FB09-4129-98F8-A991729FC2BDQ34681370-A2EE6F1C-7E71-45A2-B247-6F9E013874D9Q35269684-5308700C-C75B-46B4-9C96-0470D958B7A6Q35357735-62FD7E23-B6D1-425A-9752-F21EA84FFAB5Q35441529-918C67A2-B280-4F72-A770-D69A2D6E7735Q35525349-A75DA6D1-7270-4E8A-B38E-C779408D0471Q35553576-E79BC5A6-3A5A-4A60-A401-482DF7ECEEF5Q35939357-24E21F9C-5431-45E5-A315-397B7563ADC2Q35944713-59298966-DB02-4AEF-B567-7B1D64E095AFQ36054462-774A7A15-366F-43D3-A6B1-18B7B60EDC38Q36075677-5D9EC2C7-8CB7-41DC-8E33-42113DF89979Q36096165-98A824E6-4AD0-4FFF-A852-29C379CA2699Q36243594-9E469F3C-EC0E-416A-AA6D-19DF9FD933BDQ36249201-E05A54E3-35CA-495C-A336-9DF644A4D1ACQ36289973-810CC288-45A3-40A7-9CB3-012B5B3F8519Q36294244-3C277ADE-455C-4751-8599-EA7A4EEABD0AQ36695084-C530AEAA-B5A1-46E0-BFF3-CBC176A6E6C3Q37376363-6C8C93AA-DE66-44EF-A994-51A3E97C2BBFQ37463208-B879B38E-5CA2-49FE-A3EF-C7156DCC1C2DQ37557168-B17B4AE6-967D-4D33-BC0E-3945AF81560AQ37619759-6DEEFB86-6946-4D89-809A-829C43505A96Q38053080-AB879E7E-1EC1-4F36-8F94-36423C18F6E4Q38238738-B2FF801A-7240-4546-A884-3DA2C4EB0BAFQ38270824-262A858F-FAAF-4C2F-9BFA-482128DE58BDQ38930857-3FD18546-AEED-4079-BE42-CEDDFCD396AFQ39154555-FDB15473-4086-44CC-BDC8-1A2A5C993BA5Q39584952-D5D3397C-5086-4AAB-AA38-DAF33D8121BAQ40216414-1ACA30A0-3863-471B-877E-A4F2FFB6755BQ42432514-6A7E6755-1446-4527-8917-63A6C9CE85DA
P2860
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@en
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@nl
type
label
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@en
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@nl
prefLabel
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@en
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@nl
P2093
P2860
P356
P1433
P1476
Up for Mischief? IL-17/Th17 in the tumour microenvironment.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2010.367
P407
P577
2010-08-23T00:00:00Z